Vaccines in prophylaxis of urinary tract infections caused by the bacteria from the genus Proteus

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue

Abstract

Urinary tract infections (UTIs) pose a threat especially to women, the individuals with weakened immunity or with abnormalities in the urinary tract as well as to hospitalized and catheterized patients. The bacteria from the genus Proteus, especially P. mirabilis, are important UTI pathogenic factors. They frequently cause chronic, recurrent or severely complicated infections, resulting in the urinary stones production due to urease and other virulence factors. The ability to survive inside the stones and the increasing antibiotic resistance make it difficult to eradicate the bacteria from the urinary tract. A good solution to the problem may be the vaccination which obtained the interest from the surveyed persons, in spite of the antivaccination attitudes visible also in Poland. Currently, there are four vaccines available, composed of killed cells of different uropathogens, including Proteus spp. They are administrated intranassaly or vaginally and require many booster doses. They decrease the probability of reinfection in patients suffering from recurrent UTIs but the mechanisms of the immune response have not been exactly defined. Promising results were obtained in the studies on a mice model concerning the subunit, conjugated vaccines in which various P. mirabilis surface antigens (with the exception of flagellin) were successfully employed. Hitherto, the best results were obtained by the intranasal vaccinations, using MR/P fimbriae antigens with MPL or cholera toxin adjuvants and the antigens expressed in Lactococcus lactis or Salmonella Typhimurium. It led to an increase in the levels of the specific serum and mucosal antibodies resulting in the protection against P. mirabilis UTIs.

Authors and Affiliations

Dominika Drzewiecka, Gabriela Lewandowska

Keywords

Related Articles

Pathogenesis, prophylaxis and treatment of infections in patients with chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) patients are at high risk for infections. The pathogenesis of infection in patients with this leukemia is complex and multifactorial. Patients with CLL have a number of immune system de...

IL-18 and IL-18 binding protein concentration in ovarian follicular fluid of women with “tubal factor” subjected to in vitro fertilization

Introduction: Composition of follicular fluid is also regarded to be linked to quality of oocytes, fertilization and quality of the embryo. The aim of this study was to investigate the concentration of IL-18 and IL18BP i...

Krótkołańcuchowe kwasy tłuszczowe (SCFA) jako produkty metabolizmu bakterii jelitowych oraz ich znaczenie dla organizmu gospodarza

Bakteryjne konsorcjum jelitowe ma kluczowe znaczenie w utrzymaniu homeostazy układu odpornościowego u ssaków. Znaczącą rolę pełnią powstające w wyniku fermentacji polisacharydów metabolity bakteryjne - krótkołańcuchowe k...

Probiotic bacteria in the human gastrointestinal tract as a factor stimulating the immune system

The role of bacterial microflora of the human digestive tract in supporting the protection of the organism against food-borne pathogens and antigens is described. The effect of bacterial microflora on the immune system o...

Download PDF file
  • EP ID EP220866
  • DOI -
  • Views 146
  • Downloads 0

How To Cite

Dominika Drzewiecka, Gabriela Lewandowska (2016). Vaccines in prophylaxis of urinary tract infections caused by the bacteria from the genus Proteus. Advances in Hygiene and Experimental Medicine, 70(), 1032-1043. https://europub.co.uk/articles/-A-220866